Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06231732

The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study

Led by Sir Run Run Shaw Hospital · Updated on 2024-06-20

12

Participants Needed

1

Research Sites

37 weeks

Total Duration

On this page

Sponsors

S

Sir Run Run Shaw Hospital

Lead Sponsor

Z

Zhejiang Provincial Tongde Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is a double-blind, randomized, controlled intervention study aimed at exploring whether high-frequency transcranial alternating current stimulation (Hi-tACS) can improve cognitive impairment in patients with schizophrenia.

CONDITIONS

Official Title

The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meets the diagnostic criteria for schizophrenia according to DSM-5.
  • Age  18 years old.
  • Right-handed.
  • Willing to participate and sign informed consent; if unable, a legal guardian must consent.
  • Clinically stable and on a stable dose of antipsychotic medication for at least 4 weeks.
  • Montreal Cognitive Assessment score  10 points.
Not Eligible

You will not qualify if you...

  • Psychotic disorders caused by split affective disorder, bipolar disorder, intellectual disability, anxiety spectrum disorders, drugs, alcohol, or other psychoactive substances.
  • Severe or unstable organic diseases, history of brain tumors or epilepsy.
  • Received MECT or TMS treatment within 1 month before enrollment.
  • Compromised skin integrity at electrode placement site or allergy to electrode gel or adhesive.
  • Implants of metal or electronic devices like pacemakers, cochlear implants, deep brain stimulators, aneurysm clips, or internal fixation devices after ventriculoperitoneal shunt surgery.
  • Participation in other clinical trials within 1 month prior to baseline.
  • Pregnant or lactating women.
  • Investigator believes participation conditions are inappropriate.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhejiang Tongde Hospital

Hanzhou, Zhejiang, China, 310012

Actively Recruiting

Loading map...

Research Team

J

Jinsong Tang, Doctorate

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here